Difference between revisions of "Serimmune antibody analysis results"
| Line 38: | Line 38: | ||
|- | |- | ||
| [[User:Sprague]] || 2022-12-14 || [[File:RichardSpragueSerimmune_20211214.pdf]] || | | [[User:Sprague]] || 2022-12-14 || [[File:RichardSpragueSerimmune_20211214.pdf]] || | ||
| + | |- | ||
| + | | [[User:Igerg]] || 2022-04-13 || [[File:EXACZL_Additional_20220413.pdf]] || Tested for Lyme several times, always negative | ||
|} | |} | ||
Revision as of 20:55, 3 June 2022
The Serimmune COVID-19 Study is a longitudinal research study conducted by the Serimmune company. The study uses the company's "Serum Epitope Repertoire Analysis (SERA) technology" to study antibody responses, especially in the context of COVID-19 vaccination and exposure.
The study returns research-grade results (not intended for diagnostic clinical use) to participants. As described in the study consent document, these results are not clinically validated and not meant to serve as a clinical assay. They are, nevertheless, interesting to look at!
The study is planned to last five years, with blood samples collected every six months. Samples are self-collected by participants using a home collection kit and sent by mail.
Project Infobox 
| |
|---|---|
| Self researcher(s) | User:Madprime, User:Sprague |
| Related tools | |
| Related topics | |
Builds on project(s) |
|
| Has inspired | Projects (0) |
SARS-CoV-2 Antibody Analyses
Vaccine-only responses
| Individual | Date | Report | Notes |
|---|---|---|---|
| User:Madprime | 2022-02-03 | File:TOEAIX 20220203.pdf | Moderna vaccine (two shots, plus booster) |
| User:Sprague | 2021-12-14 | File:RichardSpragueSerimmuneCOVID 20211214.pdf | Pfizer vaccine (two shots, no booster) |
| User:Igerg | 2022-04-13 | File:EXACZL 20220413.pdf | Moderna vaccine (two shots, plus booster) - chronic spontaneous urticaria following booster |
Post-exposure responses
None yet; User:Madprime anticipates having one as they were infected with COVID-19 (positive home antigen test on 2022-05-01).
Other results
In addition to COVID-19 related antibody analyses, the study shares research analysis of antibodies related to infectious diseases (Lyme Disease, Ehrlichiosis, Anaplasmosis, Babesiosis, Chagas Disease) and autoimmune conditions (Celiac Disease).
| Individual | Date | Report | Notes |
|---|---|---|---|
| User:Madprime | 2022-02-03 | File:TOEAIX Expanded 20220203.pdf | No medical history related to these analyses. |
| User:Sprague | 2022-12-14 | File:RichardSpragueSerimmune 20211214.pdf | |
| User:Igerg | 2022-04-13 | File:EXACZL Additional 20220413.pdf | Tested for Lyme several times, always negative |
Linked content on this wiki
(The content in the table below is automatically created. See Template:Project Queries for details. If newly linked pages do not appear here, click on "More" and "Refresh".)
| Project that build on this project |
|---|
| We talked about this project in the following meetings |
|---|
| 2022-05-26 Self-Research Chat, 2022-06-02 Self-Research Chat, 2022-07-14 Self-Research Chat, 2022-09-15 Self-Research Chat, 2022-12-29 Self-Research Chat |